WHO Prequalification Updates Explained: Ultimate Guide to Global Compliance and Regulatory Trends Mastering WHO Prequalification Updates: Compliance-Ready Guide for Global Pharma and Vaccines Introduction to WHO PQ Updates and Their Importance The World Health Organization (WHO) Prequalification (PQ) Programme ensures the quality, safety, and efficacy of medicines, vaccines, diagnostics, and medical devices supplied to low- and middle-income countries. WHO PQ updates, available via the WHO official portal, reflect evolving international standards, inspection outcomes, and guidance for dossier submissions. These updates are critical for pharmaceutical companies, manufacturers, and donors involved in global procurement programs such as Gavi and UNICEF. By 2025,…

WHO Prequalification Programme Overview and Latest Updates – pharmaceutical regulatory agencies WHO Prequalification Programme Overview and Latest Updates The World Health Organization (WHO) Prequalification Programme plays a pivotal role in ensuring that pharmaceutical products satisfy required safety, efficacy, and quality standards, especially in low and middle-income countries. For professionals engaged with pharmaceutical regulatory agencies, staying informed about this programme and its updates is critical for global health initiatives. This guide will walk you through the essentials of the WHO Prequalification Programme, recent updates, and their implications for regulatory compliance in the pharmaceutical industry. 1. Understanding the WHO Prequalification Programme The…

New WHO Guidelines for Vaccines and Biologics PQ (2025) – regulatory agencies for pharmaceutical New WHO Guidelines for Vaccines and Biologics PQ (2025): A Comprehensive Guide for Regulatory Agencies The World Health Organization (WHO) plays a pivotal role in shaping the regulatory landscape for vaccines and biologics through its Prequalification (PQ) program. The updated guidelines slated for 2025 introduce significant changes that will impact regulatory agencies for pharmaceutical products across the globe. This tutorial serves as a thorough guide on the new guidelines and offers actionable insights for effective compliance and implementation. 1. Understanding the WHO PQ Program Prior to…

PQ Requirements for APIs, FDCs, and Diagnostic Kits – clinical safety and pharmacovigilance PQ Requirements for APIs, FDCs, and Diagnostic Kits – Clinical Safety and Pharmacovigilance The introduction of updated PQ (Prequalification) requirements for Active Pharmaceutical Ingredients (APIs), Fixed-Dose Combinations (FDCs), and Diagnostic Kits is transforming the landscape of clinical safety and pharmacovigilance globally. This guide is designed for professionals engaged in the pharmaceutical industry regulatory compliance across regions including the US, EU, India, Canada, and Australia. This tutorial outlines step-by-step protocols and current expectations as they align with ICH and WHO frameworks, emphasizing the importance of maintaining regulatory compliance…

How to Submit a Dossier to WHO Prequalification – pharmaceutical industry regulatory compliance How to Submit a Dossier to WHO Prequalification The World Health Organization (WHO) Prequalification Programme serves as a pivotal framework in facilitating the provision of safe, effective, and quality medicines and vaccines to underserved populations worldwide. Efficient submission of a dossier to WHO Prequalification requires a thorough understanding of regulatory compliance requirements, guidelines, and processes as outlined by WHO. This tutorial provides a step-by-step guide for professionals in the pharmaceutical industry aiming for regulatory compliance in pharmaceutical industry practices. 1. Understanding the WHO Prequalification Programme The WHO…

Recent WHO PQ Policy Changes and Assessment Criteria – pharmaceutical industry regulatory compliance Recent WHO PQ Policy Changes and Assessment Criteria The World Health Organization (WHO) Prequalification (PQ) Programme plays a vital role in ensuring that pharmaceuticals meet the necessary quality, safety, and efficacy standards for specific health needs. It is crucial for stakeholders in the pharmaceutical industry to remain compliant with the latest WHO PQ policies and assessment criteria. This article serves as a step-by-step guide through the recent updates and how they impact regulatory compliance in the pharmaceutical industry. 1. Understanding WHO PQ and Its Relevance The WHO…

WHO Collaborative Registration Procedures: Global Impact – regulatory compliance in pharmaceutical industry WHO Collaborative Registration Procedures: Global Impact on Regulatory Compliance in the Pharmaceutical Industry The pharmaceutical industry is under constant scrutiny to maintain high standards of quality and compliance. As regulations evolve globally, entities operating in this sector must stay informed and adapt to these changes to ensure successful product registration and market access. This comprehensive guide examines the World Health Organization (WHO) Collaborative Registration Procedures and their implications for regulatory compliance in the pharmaceutical industry. We will explore this topic in detail, focusing on the updates expected in…

How WHO PQ Supports Procurement via UN Agencies – pharmaceutical industry regulatory compliance How WHO PQ Supports Procurement via UN Agencies – pharmaceutical industry regulatory compliance The World Health Organization (WHO) Prequalification (PQ) program plays a crucial role in ensuring that essential medicines and vaccines meet global quality standards. Procurement processes, especially those undertaken by United Nations (UN) agencies, rely heavily on the assurance of this quality. This article outlines the steps necessary for navigating the pharmaceutical industry regulatory compliance landscape concerning WHO PQ, especially in the context of global procurement. Understanding WHO PQ: An Overview The WHO Prequalification program…

Prequalified Product List Monitoring: How Often It Changes – regulatory compliance in pharmaceutical industry Prequalified Product List Monitoring: How Often It Changes The monitoring of the WHO Prequalified (PQ) Product List is an essential component in ensuring regulatory compliance in pharmaceutical industry. The dynamic nature of this list necessitates regular scrutiny to maintain adherence to current standards. This article will guide professionals in the regulatory affairs and clinical operations fields through the process of monitoring the PQ list, highlighting significant changes, implications for drug safety, and maintaining compliance with regulations. Understanding WHO Prequalification and Its Significance The World Health Organization…

Dossier Review Timelines and PQ Inspections: What to Expect – regulatory compliance in pharmaceutical industry Dossier Review Timelines and PQ Inspections: What to Expect In the rapidly evolving landscape of global pharmaceuticals, maintaining effective regulatory compliance is crucial for the successful development, approval, and post-marketing surveillance of medicinal products. The WHO prequalification (PQ) program primarily aims to improve access to quality, safe, and effective medicines. This article delves into the regulatory compliance aspects surrounding dossier review timelines and PQ inspections, providing essential insights for professionals in regulatory affairs, pharmacovigilance, and clinical operations across various jurisdictions, including the US, EU, Canada,…